Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cotinga Pharmaceuticals Inc COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.


GREY:COTQF - Post by User

Post by Cotitwoon Oct 22, 2019 11:43am
719 Views
Post# 30254932

Cotinga Still Alive and Kicking

Cotinga Still Alive and KickingStock was halted because the financials were filed late. Problem has been worked out and we should be trading next week
The company has a very Busy week planned
Dr Richard Ho returned from a long weekend in Ireland where he presented at a Conference and also met with John Crown head of oncology at St Vincents Hospital in Dublin to discuss the planned Triple Negative Breast Cancer trial combining Coti 2 with Erbulin a drug currently used for
TNBC ( we have to raise money for this study)
Both Alison and Dr Ho arrived in San Francisco last nite to attend a Bio Conference where they have 16 meetings set up over the next 2 days
The company has also had TWO requests from 2 Major Pharma companies requesting a package of information  on Coti 2
One of the companies has reached out to Alison and they have set up a Conference call this Friday to discuss Coti 2
Also this Friday or Monday we should find out if patient 3 in Cohort 3 has completed there first cycle and if so we move on to Cohort 4  Some of the companies shareholders have stepped forward and are raising some funds for the company
I met with Alison and John Drake and they are going to keep this company going, the reason being They believe in Coti 2 
By the way Both Alison and Dr Ho have worked the last 13 months with NO PAY 
<< Previous
Bullboard Posts
Next >>